Pages that link to "Q39496895"
Jump to navigation
Jump to search
The following pages link to Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: a beneficial strategy to combat non-small cell lung cancer (Q39496895):
Displaying 25 items.
- A kinase-independent role for EGF receptor in autophagy initiation (Q24314943) (← links)
- EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance (Q24335999) (← links)
- Autophagy modulation as a potential therapeutic target for diverse diseases (Q27010076) (← links)
- In vitro and in vivo models for analysis of resistance to anticancer molecular therapies (Q27014174) (← links)
- Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data (Q28544631) (← links)
- FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells (Q33742954) (← links)
- Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers (Q35161318) (← links)
- Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells (Q36116239) (← links)
- EGFR tyrosine kinase inhibition induces autophagy in cancer cells (Q36524211) (← links)
- Interaction between Her2 and Beclin-1 proteins underlies a new mechanism of reciprocal regulation (Q37012420) (← links)
- Metabolism addiction in pancreatic cancer (Q37620679) (← links)
- Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer (Q37690890) (← links)
- Paradoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells (Q37706156) (← links)
- Therapeutic targets in cancer cell metabolism and autophagy (Q38025264) (← links)
- Autophagy: a potential therapeutic target in lung diseases (Q38109605) (← links)
- EGFR inhibitors and autophagy in cancer treatment (Q38257898) (← links)
- The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism? (Q38612793) (← links)
- Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer (Q38868651) (← links)
- Developing an Agent-Based Drug Model to Investigate the Synergistic Effects of Drug Combinations (Q47310421) (← links)
- Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis. (Q54315299) (← links)
- The anti-tumour effect of Mel and its role in autophagy in human hepatocellular carcinoma cells (Q64260814) (← links)
- Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death. (Q64893377) (← links)
- Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management (Q89126294) (← links)
- Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems (Q90311831) (← links)
- A novel Diels-Alder adduct of mulberry leaves exerts anticancer effect through autophagy-mediated cell death (Q98568570) (← links)